The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as obesity rates continue to rise.
You must log in or register to comment.
Drugs where the knowledge of their long term impacts is unknown vs. Encouraging manufacturers not to make sugar-loaded everything.
I’ll take untested drugs for $400, Alex. - the WHO, apparently
Wait til food manufacturers figure out how to bypass glp-1 appetite suppression



